Publications by authors named "Line S Tarpgaard"

Claim this Profile
U
Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer.
Sharuya Kulatheivam, Lea Lecanda Mariager Jakobsen, Mark Burton, Alan P Ainsworth, Claus Fristrup, Line S Tarpgaard

Pathol Res Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New dosing schedules in pre-treated patients with metastatic colorectal cancer.
Per Pfeiffer, Line Schmidt Tarpgaard

J Gastrointest Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer.
Susy Shim, Anke Reinacher-Schick, Anna-Lena Kraeft, Per Pfeiffer, Line Schmidt Tarpgaard

Invest New Drugs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial.
Ismail Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, Mustafa Bulut, Torben Frøstrup Hansen

Ann Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).
Sönke Detlefsen, Mark Burton, Alan P Ainsworth, Claus Fristrup, Martin Graversen, Line S Tarpgaard

Pleura Peritoneum· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Ingrid Terese Foslund, Sahra Aisha Vinholt von Magius, Alan Patrick Ainsworth, Sönke Detlefsen, Claus Wilki Fristrup, Line Schmidt Tarpgaard

Pleura Peritoneum· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Charlotte G Kryh-Jensen, Claus W Fristrup, Alan P Ainsworth, Sönke Detlefsen, Michael B Mortensen, Line S Tarpgaard

Pleura Peritoneum· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies.
Line Schmidt Tarpgaard, Stine Brændegaard Winther, Per Pfeiffer

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol.
Tobias Freyberg Justesen, Ismail Gögenur, Line Schmidt Tarpgaard, Per Pfeiffer, Camilla Qvortrup

BMJ Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Mojib Fallah, Sönke Detlefsen, Alan P Ainsworth, Claus W Fristrup, Michael B Mortensen, Line S Tarpgaard

Pleura Peritoneum· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New use for old drugs: Epirubicin in colorectal cancer.
Line S Tarpgaard, Camilla Qvortrup, Signe L Nielsen, Jan Stenvang, Sönke Detlefsen

Acta Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in patients with cancer during the COVID-19 pandemic - a Danish cross-sectional study (COPICADS).
Stefan S Jeppesen, Kristian K Bentsen, Trine L Jørgensen, Hanne S Holm, Linda Holst-Christensen, Line S Tarpgaard

Acta Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.
Jesper Andreas Palshof, Estrid Vilma Solyom Høgdall, Tim Svenstrup Poulsen, Dorte Linnemann, Benny Vittrup Jensen, Line Schmidt Tarpgaard

BMC Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.
Line S Tarpgaard, Maj Sofie Ørum-Madsen, Ib J Christensen, Cathrine Nordgaard, Julie Noer

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.
Mads Heilskov Rasmussen, Iben Lyskjær, Rosa Rakownikow Jersie-Christensen, Line Schmidt Tarpgaard, Bjarke Primdal-Bengtson

Nat Commun· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
Line S Tarpgaard, Camilla Qvortrup, Sune B Nygård, Signe L Nielsen, Diana R Andersen

BMC Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab.
Line S Tarpgaard, Ib J Christensen, Gunilla Høyer-Hansen, Ida K Lund, Tormod K Guren

Int J Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.
Mogens K Boisen, Christian Dehlendorff, Dorte Linnemann, Boye S Nielsen, Jim S Larsen, Line S Tarpgaard

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.
Niels F Jensen, Jan Stenvang, Mette K Beck, Barbora Hanáková, Kirstine C Belling, Line S Tarpgaard

Mol Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer.
Xue Lin, Jan Stenvang, Mads Heilskov Rasmussen, Shida Zhu, Niels Frank Jensen, Line S Tarpgaard

BMC Genomics· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study.
Line S Tarpgaard, Tormod K Guren, Bengt Glimelius, Ib J Christensen, Per Pfeiffer

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.
Mads H Rasmussen, Niels F Jensen, Line S Tarpgaard, Camilla Qvortrup, Maria U Rømer

Mol Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis